Cerium-Doped Fused-Silica Fibers as Wavelength Shifters

We have evaluated the performance of a Ce-doped fused-silica fiber as wavelength shifter coupled to a CeF$_{3}$ crystal using electron beams at CERN. The pulse shape and collection efficiency were measured using irradiated (100 kGy) and un-irradiated fibers. In addition, we evaluated the light yield of various Ce-doped fibers and explored the possibility of using them in the future, including for precision timing applications in a high-luminosity collider environment.Comment: 11 pages, 7 figure

The effects of incremental brightness and contrast adjustments on radiographic data: A quantitative study

PubMed ID: 15709101Objectives: To determine the border level of brightness and contrast changes in order to prevent the loss of originality of the quantitative data on digital dental radiographs. Methods: After measuring the baseline mean grey values (MGVs) of a fixed region of interest on the alveolar bone and an aluminium step wedge, incremental brightness and contrast adjustments were performed on a digital periapical radiograph. The distribution of the data was analysed to investigate the significance of the changes on radiodensitometric data after incremental increase of brightness and contrast. Results: The original MGVs were easily retrieved after brightness adjustments; however, the contrast increase led to more complicated density changes. The originality of the data was saved up to 50 units of contrast increase, but further than this limit, significant radiodensitometric changes occurred. Conclusions: Contrast adjustments should be performed cautiously when making quantitative analyses on the digital radiographs. © 2005 The British Institute of Radiology

Expanding the clinical and immunological phenotypes and natural history of MALT1 deficiency.

Purpose: MALT1 deficiency is a combined immune deficiency characterized by recurrent infections, eczema, chronic diarrhea, and failure to thrive. Clinical and immunological characterizations of the disease have not been previously reported in large cohorts. We sought to determine the clinical, immunological, genetic features, and the natural history of MALT-1 deficiency. Methods: The clinical findings and treatment outcomes were evaluated in nine new MALT1-deficient patients. Peripheral lymphocyte subset analyses, cytokine secretion, and proliferation assays were performed. We also analyzed ten previously reported patients to comprehensively evaluate genotype/phenotype correlation. Results: The mean age of patients and disease onset were 33 ± 17 and 1.6 ± 0.7 months, respectively. The main clinical findings of the disease were recurrent infections (100%), skin involvement (100%), failure to thrive (100%), oral lesions (67%), chronic diarrhea (56%), and autoimmunity (44%). Eosinophilia and high IgE were observed in six (67%) and two (22%) patients, respectively. The majority of patients had normal T and NK cells, while eight (89%) exhibited reduced B cells. Immunoglobulin replacement and antibiotics prophylaxis were mostly ineffective in reducing the frequency of infections and other complications. One patient received hematopoietic stem cell transplantation (HSCT) and five patients died as a complication of life-threatening infections. Analyzing this cohort with reported patients revealed overall survival in 58% (11/19), which was higher in patients who underwent HSCT (P = 0.03). Conclusion: This cohort provides the largest analysis for clinical and immunological features of MALT1 deficiency. HSCT should be offered as a curative therapeutic option for all patients at the early stage of life